Synthesis and characterization of modified magnetic nanoparticles as theranostic agents: in vitro safety assessment in healthy cells.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 11 09 2020
revised: 24 12 2020
accepted: 11 01 2021
pubmed: 19 1 2021
medline: 25 2 2023
entrez: 18 1 2021
Statut: ppublish

Résumé

Over the past few decades nanotechnology has paved its way into cancer treatment procedures with the use of nanoparticles (NPs) for contrast media and therapeutic agents. Iron based NPs are the most investigated since they can be used for drug delivery, imaging and when magnetically activate employed as local heat sources in cancer hyperthermia. In this work, was performed synthesis, characterization and biological evaluation of different types of iron oxide nanoparticles (mNPs'), as promising material for tumor hyperthermia. The surface of mNPs' has modified with inorganic stabilizing agents to particularly improve characteristics such as their magnetic properties, colloidal stability and biocompatibility. The successful coating of mNPs' was confirmed by morphological and structural characterization by transmission electron microscopy (TEM) and Fourier-Transform Infra-Red spectroscopy (FT-IR), while their hydrodynamic diameter was studied by using Dynamic light scattering (DLS). X-ray Diffraction (XRD) proved that the crystallite phase of mNPs' is the same with the pattern of magnetite. Superparamagnetic behavior and mNPs' response under the application of alternating magnetic field (AMF) were also thoroughly investigated and showed good heating efficiency in magnetic hyperthermia experiments. The contrast ability in magnetic resonance imaging (MRI) is also discussed indicating that mNPs are negative MRI contrast types. Nonetheless the effects of mNPs on cell viability was performed by MTT on human keratinocytes, human embryonic kidney cells, endothelial cells and by hemolytic assay on erythrocytes. In healthy keratinocytes wound healing assay in different time intervals was performed, assessing both the cell migration and wound closure. Endothelial cells have also been studied in functional activity performing capillary morphogenesis. In vitro studies showed that mNPs are safely taken by the healthy cells and do not interfere with the biological processes such as cell migration and motility.

Identifiants

pubmed: 33460736
pii: S0887-2333(21)00019-9
doi: 10.1016/j.tiv.2021.105094
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105094

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Danai Prokopiou E (D)

Inorganic Chemistry Laboratory, Chemistry Department, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou 157 71, Greece; Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", 153 41 Aghia Paraskevi Attikis, Greece.

Michael Pissas (M)

Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", 153 41 Aghia Paraskevi Attikis, Greece.

Gabriella Fibbi (G)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale G.B. Morgagni, 50, Florence 50134, Italy.

Francesca Margheri (F)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale G.B. Morgagni, 50, Florence 50134, Italy.

Beata Kalska-Szostko (B)

Institute of Chemistry, Faculty of Biology and Chemistry, University of Bialystok, Ciołkowskiego 1K, Białystok 15-245, Poland.

Giorgos Papanastasiou (G)

Edinburgh Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.

Maurits Jansen (M)

Edinburgh Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.

Jansen Wang (J)

Edinburgh Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.

Anna Laurenzana (A)

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale G.B. Morgagni, 50, Florence 50134, Italy. Electronic address: anna.laurenzana@unifi.it.

Eleni Efthimiadou K (E)

Inorganic Chemistry Laboratory, Chemistry Department, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou 157 71, Greece; Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", 153 41 Aghia Paraskevi Attikis, Greece. Electronic address: efthim@chem.uoa.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH